Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,389 | -3,295 | -21,278 | -19,726 | -42,009 |
| Depreciation Amortization | 2,702 | 1,341 | 8,670 | 7,131 | 6,383 |
| Accounts receivable | -7,126 | 1,026 | -826 | 2,353 | 2,422 |
| Other Working Capital | -22,687 | -15,426 | 785 | 10,095 | 7,732 |
| Other Operating Activity | 9,528 | 1,845 | -5,645 | -12,115 | 15,783 |
| Operating Cash Flow | $-19,972 | $-14,509 | $-18,294 | $-12,262 | $-9,689 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -946 | -640 | -1,721 | -714 | -893 |
| Net Acquisitions | 2,433 | 2,433 | 43,384 | 43,474 | N/A |
| Other Investing Activity | -59 | 3 | -1,280 | -1,991 | -739 |
| Investing Cash Flow | $1,428 | $1,796 | $40,383 | $40,769 | $-1,632 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 8,770 | -4,661 | -5,632 | -4,861 |
| Debt Issued | 9,547 | -277 | 23,600 | 15,376 | 5,376 |
| Debt Repayment | -481 | N/A | -22,515 | -3,968 | -1,872 |
| Common Stock Issued | 65 | 49 | 308 | 285 | 263 |
| Common Stock Repurchased | -9 | -9 | -14 | N/A | N/A |
| Other Financing Activity | -40 | -19 | -12,761 | -1,546 | -1,138 |
| Financing Cash Flow | $9,082 | $8,514 | $-16,043 | $4,515 | $-2,232 |
| Exchange Rate Effect | 735 | 802 | 1,429 | 2,944 | 129 |
| Beginning Cash Position | 21,651 | 21,651 | 16,143 | 16,397 | 16,397 |
| End Cash Position | 12,782 | 18,171 | 21,651 | 50,278 | 4,609 |
| Net Cash Flow | $-8,869 | $-3,480 | $5,508 | $33,881 | $-11,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,972 | -14,509 | -18,294 | -12,262 | -9,689 |
| Capital Expenditure | -946 | -640 | -1,721 | -726 | -905 |
| Free Cash Flow | -20,918 | -15,149 | -20,015 | -12,988 | -10,594 |